The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and toxicity of BRAF targeted therapy in elderly patients with melanoma.
 
Ronen Stoff
Honoraria - Bristol-Myers Squibb Israel; Medison; Merck Serono; Merck Sharp & Dohme; Novartis; Roche Israel
Consulting or Advisory Role - Pangaea Biotech
 
Svetomir Markovic
Stock and Other Ownership Interests - Sorrento Therapeutics
Consulting or Advisory Role - Sorrento Therapeutics
Research Funding - Bristol-Myers Squibb; Nektar; Sorrento Therapeutics
Patents, Royalties, Other Intellectual Property - Nanoparticles (patents); Nanoparticles - immunoconjugates
 
Robert R. McWilliams
Stock and Other Ownership Interests - Zentalis
Consulting or Advisory Role - Zentalis
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Merck (Inst); Newlink Genetics (Inst)
 
Lisa A. Kottschade
Consulting or Advisory Role - Immunocore
 
Heather N. Montane
No Relationships to Disclose
 
Anastasios Dimou
Honoraria - Intellisphere; Intellisphere (Inst); Intellisphere (Inst); Roche/Genentech
Consulting or Advisory Role - Anheart Therapeutics; ChromaCode; Guardant Health (Inst); TP Therapeutics (Inst)
Research Funding - Anheart Therapeutics (Inst); AstraZeneca (Inst); Guardant Health; Merck; Novartis (Inst); Sorrento Therapeutics (Inst); Syntrix Biosystems (Inst)
Travel, Accommodations, Expenses - Guardant Health
Other Relationship - Rising Tide Foundation (Inst)
 
Arkadiusz Z. Dudek
Leadership - IGF Oncology; TTC Oncology
Stock and Other Ownership Interests - IGF Oncology; Martell diagnostic; Squarex Pharma; TTC Oncology
Consulting or Advisory Role - HiberCell
Patents, Royalties, Other Intellectual Property - IGF Oncology
 
Yiyi Yan
No Relationships to Disclose
 
Winston Tan
Honoraria - Medscape; Onclive
 
Roxana Stefania Dronca
Honoraria - Eisai; Elsevier; EMD Serono; Natera
Consulting or Advisory Role - Eisai; Elsevier; EMD Serono; Genzyme; Natera
Research Funding - Alkermes (Inst); BMSi (Inst); Emerson Collective (Inst); Merck Sharp & Dohme (Inst); Phosplatin Therapeutics (Inst); Regeneron (Inst); Regeneron (Inst); Sorrento Therapeutics (Inst); Spirita (Inst)
Other Relationship - Elsevier
 
Mahesh Seetharam
Honoraria - AADi; Daiichi Sankyo; Deciphera; Horizon CME
Travel, Accommodations, Expenses - Horizon CME
 
Ruqin Chen
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I); Lilly
 
Matthew Stephen Block
Research Funding - Alkermes; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Immune Design (Inst); Marker, Inc. (Inst); Merck (Inst); nference; Pharmacyclics (Inst); Regeneron; Sorrento Therapeutics (Inst); TILT Biotherapeutics; Transgene (Inst); Viewpoint Molecular Targeting
(OPTIONAL) Uncompensated Relationships - Sorrento Therapeutics; TILT Biotherapeutics; Viewpoint Molecular Targeting